Avkare Incorporated
Avkare Incorporated appears in FDA public data with 5 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-1174-2018, Class II) was initiated on July 18, 2018.
Summary
- Total Recalls
- 5
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-1174-2018 | Class II | AvKARE Valsartan and Hydrochlorothiazide 160 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactu | July 18, 2018 |
| D-1177-2018 | Class II | AvKARE Valsartan and Hydrochlorothiazide 320 mg/25 mg tablets 90-count bottle, Rx Only, Manufactured | July 18, 2018 |
| D-1173-2018 | Class II | AvKARE Valsartan and Hydrochlorothiazide 80 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactur | July 18, 2018 |
| D-1176-2018 | Class II | AvKARE Valsartan and Hydrochlorothiazide 320 mg/12.5 mg tablets, 90-count bottle, Rx Only, Manufactu | July 18, 2018 |
| D-1175-2018 | Class II | AvKARE Valsartan and Hydrochlorothiazide 160 mg/25 mg tablets, 90-count bottle, Rx Only, Manufacture | July 18, 2018 |